bis(diazo)benzidine has been researched along with maraviroc in 1 studies
| Studies (bis(diazo)benzidine) | Trials (bis(diazo)benzidine) | Recent Studies (post-2010) (bis(diazo)benzidine) | Studies (maraviroc) | Trials (maraviroc) | Recent Studies (post-2010) (maraviroc) |
|---|---|---|---|---|---|
| 28 | 0 | 6 | 785 | 124 | 539 |
| Protein | Taxonomy | bis(diazo)benzidine (IC50) | maraviroc (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.1 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0014 | |
| C-C chemokine receptor type 5 | Homo sapiens (human) | 0.0044 | |
| C-C chemokine receptor type 5 | Mus musculus (house mouse) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appiah-Kubi, P; Iwuchukwu, EA; Soliman, MES | 1 |
1 other study(ies) available for bis(diazo)benzidine and maraviroc
| Article | Year |
|---|---|
Structure-based identification of novel scaffolds as potential HIV-1 entry inhibitors involving CCR5.
Topics: CCR5 Receptor Antagonists; Cyclohexanes; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Receptors, CCR5; Receptors, Chemokine; Triazoles | 2022 |